OPK

OPKO Health, Inc. (NASDAQ:OPK) is a diversified healthcare company founded in 1991 and headquartered in Miami, Florida. The company went public in 1995 and operates through two primary business segments: diagnostics and pharmaceuticals. OPKO has evolved from a traditional pharmaceutical company into a broader healthcare enterprise that combines laboratory testing services with drug development and commercialization. The company operates internationally across the United States, Ireland, Chile, Spain, Israel, and Mexico, serving healthcare providers, patients, and pharmaceutical partners through its integrated platform of diagnostic services and therapeutic products.